Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 58
Filter
Add more filters










Publication year range
1.
Georgian Med News ; (167): 7-16, 2009 Feb.
Article in German | MEDLINE | ID: mdl-19276460

ABSTRACT

Nitric oxide (NO) has been identified an important neurotransmitter involved in the control of the human urinary tract. It has been suggested that NO is one of the factors keeping the bladder relaxed during the filling phase. This function might be mediated by the NO-induced elevation of intracellular cyclic GMP. Prostaglandins (PG) are known to exert contractile effects on the bladder smooth musculature, especially in pathological conditions. The aim of the present study was to examine the effects of a new class of NO donor drugs, combining both anti-phlogistic and NO-donating activity (NCX 2111 and HCT 1026), on the contraction induced by PG or electrical field stimulation (EFS) of isolated human detrusor. Effects were compared to those of sodium nitroprusside (SNP), forskolin, tolterodine, and oxybutynin. Using the organ bath technique, drug effects on the contraction induced by PG ((F2 alpha)) or EFS of isolated human detrusor smooth muscle were investigated. Detrusor strips were also exposed to increasing concentrations of the compounds (0.1 microM - 10 microM) and the accumulation of cyclic GMP and cyclic AMP was determined by means of radioimmunoassays. The tension induced by PG was dose-dependently reversed by the drugs. The rank order of efficacy was: forskolin > SNP > NCX 2111 > HCT 1026. R(max) values ranged from 57% (forskolin) to 24% (HCT 1026). Compounds also dose-dependently reduced the amplitudes of contraction induced by EFS (tolterodine > oxybutynin > NNP = forskolin > HCT 1026 > 2111). The effects of forskolin, HCT 1026, NCX 2111 and SNP were paralleled by an increase in cyclic AMP or cyclic GMP. Our results provide evidence that the NO-cGMP pathway is not of utmost significance in the control of human detrusor smooth muscle. In vitro, the combination of NO-donating with anti-phlogistic activity does not seem to be of functional advantage with regard to the facilitation of detrusor relaxation.


Subject(s)
Anti-Infective Agents/pharmacology , Anti-Infective Agents/therapeutic use , Flurbiprofen/analogs & derivatives , Muscle, Smooth , Nitric Oxide/metabolism , Urinary Bladder, Overactive/drug therapy , Cyclic GMP/metabolism , Flurbiprofen/pharmacology , Humans , In Vitro Techniques , Muscle, Smooth/drug effects , Muscle, Smooth/metabolism , Muscle, Smooth/pathology , Urinary Bladder, Overactive/metabolism , Urinary Bladder, Overactive/pathology
5.
Zentralbl Gynakol ; 98(26): 1641-4, 1976.
Article in German | MEDLINE | ID: mdl-1020523

ABSTRACT

The concentration of serum protein was determined in 227 women during the 11th to 13th, 24th to 26th and 33rd to 35th week of pregnancy as well as immediately after delivery and on the 7th day post partum according to the Biuret method. A small but significant decrease of protein was observed during the second trimester of pregnancy (Ist Trimester x(-) = 7,57; IInd Trimester x(-) = 7,26 g/100 ml). The lowest values was found immediately after delivery (x(-) = 6,86). The mean concentration on the 7th day post partum was increased again (x(-) = 7,37). The values were compared with there of 190 non-pregnant women (x(-) = 7,57).


Subject(s)
Blood Proteins/analysis , Female , Humans , Labor, Obstetric , Longitudinal Studies , Postpartum Period , Pregnancy
6.
Zentralbl Gynakol ; 98(21): 1287-95, 1976.
Article in German | MEDLINE | ID: mdl-1007686

ABSTRACT

From 50 normal births blood of mother and child was examined simultaneously at three different times, meant for determination of 13 biochemical parameters. Evaluation of the measured values was done by the multivariate method of discriminance analysis. Basing on the observed data problems of discriminance analysis are dealt with in an introductive way. The perinatal example is used to demonstrate how in the case of a complex problem connections may be better visible by this method, though detailed informations are lost.


Subject(s)
Perinatology , Adenosine Triphosphate/blood , Analysis of Variance , Blood Glucose/analysis , Carbon Dioxide/blood , Female , Humans , Infant, Newborn , Labor, Obstetric , Lactates/blood , Oxygen/blood , Partial Pressure , Pregnancy , Pyruvates/blood
7.
Zentralbl Gynakol ; 98(18): 1089-102, 1976.
Article in German | MEDLINE | ID: mdl-983486

ABSTRACT

The essential EPH-gestosis seems to have multiple aetiological factors and the disease develops already a long time before the appearance of the classical symptoms. The disturbed renal function is the main point among secondary pathological effects as the damaged placenta, the disseminated coagulation, the glomerular endotheliosis, the increased retention of water and sodium with increased arterial responsiveness. It may be that this reduced reversible renal function is of extra-renal origin. As predisposing factors were discussed the reduced uteroplacental circulation with the release of still unknown pressor substances or decreased inactivation of pressor amines, the uterorenal reflex mechanism, the disturbed homeostasis of the body fluids and the vegetativ-hypothalamic crisis etc. But other factors may also be participate on this disease as immunological and hormonal aspects, especially the renin-angiotensin-aldosteron-system and prostaglandins. To find out the aetiological factors we should examine the disease at the beginning in comparison with normal pregnancy. These factors must explain why the true EPH-gestosis appears mainly during the first pregnancy and frequently in twins and so on.


Subject(s)
Pre-Eclampsia/etiology , Aldosterone/physiology , Angiotensin II/physiology , Animals , Biogenic Amines/physiology , Blood Volume , Body Fluids/physiology , Edema/physiopathology , Female , Fibrin Fibrinogen Degradation Products/physiology , Hormones/physiology , Humans , Hypertension/etiology , Immunity , Kidney Diseases/etiology , Nutritional Physiological Phenomena , Placenta/blood supply , Pregnancy , Prostaglandins/physiology , Proteinuria/etiology , Renin/physiology , Uterus/blood supply , Uterus/physiology , Vasoconstrictor Agents/physiology
8.
Zentralbl Gynakol ; 98(13): 795-804, 1976.
Article in German | MEDLINE | ID: mdl-961183

ABSTRACT

832 estimations of heat stable alkaline phosphatase (HSAP) and of heat alkaline phosphatase (HLAP) were carried out simultaneously in late pregnant women at 25th to the 42nd weeks of pregnancy. 147 of them delivered children with normal birth-weight. All these women suffered from pre-eclampsia, hypertension or any kind of superimposed pre-eclampsia. 110 other pregnant women with or without symptoms of pre-eclampsia gave birth to small for dates babies. In addition, the values of these patients were compared with 372 estimations of the same enzymes carried out in 120 patients with normal pregnancy and outcome of normal weighted children. The site of the values of every group showed no typical correlation to the course and outcome of their pregnancy. Regarding four special criterions it was possible to give a good prediction by serial determinations for the weight of the newborn in 80 per cent of the cases. A correlation between the urinary excretion of total oestrogens as well as HLAP and the values of HSAP was to be found only in some groups of patients.


Subject(s)
Alkaline Phosphatase/blood , Pre-Eclampsia/enzymology , Birth Weight , Chronic Disease , Female , Humans , Hypertension/enzymology , Infant, Newborn , Pregnancy , Pregnancy Complications, Cardiovascular/enzymology , Time Factors
9.
Prostaglandins ; 11(1): 109-21, 1976 Jan.
Article in English | MEDLINE | ID: mdl-3823

ABSTRACT

11 pregnancies at term were terminated by dilatation of the uterine cervix, low amniotomy, and by intravenous administration of PGF2alpha. The average infusion time was 3 hours 55 minutes, and the average total dose of PGF2alpha amounted to 2.0 mg. Parameters of acid-base changes, carbohydrate and energic state changes, gas metabolism, and changes in coagulation and fibrinolysis in mother and in fetus were analyzed during labor and after birth. Labor activity and fetal cardiac action were monitored cardiotocographically. Checked against 50 uncomplicated spontaneous deliveries, we found no disadvantageous changes in the parameters investigated.


Subject(s)
Labor, Induced , Prostaglandins F/therapeutic use , Acid-Base Equilibrium/drug effects , Blood Coagulation/drug effects , Carbohydrate Metabolism , Carbon Dioxide/blood , Female , Fetus/metabolism , Fibrinolysis/drug effects , Humans , Hydrogen-Ion Concentration , Infant, Newborn , Injections, Intravenous , Maternal-Fetal Exchange , Oxygen/blood , Partial Pressure , Pregnancy , Prostaglandins F/administration & dosage , Prostaglandins F/pharmacology
11.
Z Geburtshilfe Perinatol ; 179(2): 125-31, 1975 Apr.
Article in German | MEDLINE | ID: mdl-239495

ABSTRACT

11 pregnancies at term were terminated by dilatation of the uterine cervix, low amniotomy, and by intravenous administration of PGE2. The average infusion time was 4 hours 20 minutes, and the average total dose of PGE2 amounted to 0.2 mg. Parameters of acid-base changes, carbohydrate and energic state changes, gas metabolism, and changes in coagulation and fibrinolysis in mother and in fetus were analysed during labor and after birth. Labor activity and fetal cardiac action were monitored cardiotocographically. Checked against 50 uncomplicated spontaneous deliveries, we have found no disadvantageous changes in the parameters investigated.


Subject(s)
Blood Coagulation/drug effects , Fetal Blood/drug effects , Labor, Induced , Maternal-Fetal Exchange , Prostaglandins E/pharmacology , Acid-Base Equilibrium/drug effects , Adenosine Triphosphate/blood , Blood Glucose/metabolism , Blood Platelets/drug effects , Carbon Dioxide/blood , Female , Fetal Blood/analysis , Humans , Hydrogen-Ion Concentration , Infant, Newborn , Injections, Intravenous , Lactates/blood , Oxygen/blood , Partial Pressure , Pregnancy , Prostaglandins E/adverse effects , Pyruvates/blood , Umbilical Arteries , Umbilical Veins , Uterine Inertia/blood
12.
Zentralbl Gynakol ; 97(23): 1458-63, 1975.
Article in German | MEDLINE | ID: mdl-1210874

ABSTRACT

On 120 patients, during normal pregnancy, from the 17th to the 42nd week of pregnancy, 372 heat labile alkaline phosphatase estimations were carried out by means of the 4-nitrophenol method. In addition to that, after incubation of sera at 65 degrees C for 30 minutes, the activity of the heat stable placental isoenzyme was checked. With progressing pregnancy, the heat stable fraction rises significantly and the heat labile fraction of total alkaline phosphatase increases slightly. There is a correlation between the readings of the two fractions. In 169 cases, the total urinary oestrogen output correlates also with the heat stable alkaline phosphatase.


Subject(s)
Alkaline Phosphatase/blood , Pregnancy , Female , Gestational Age , Humans , Isoenzymes/blood , Placenta/enzymology , Placenta Diseases/enzymology , Regression Analysis , Temperature
13.
Zentralbl Gynakol ; 97(26): 1614-25, 1975.
Article in German | MEDLINE | ID: mdl-1210877

ABSTRACT

22 pregnancies at term were terminated by dilatation of the uterine cervix, low amniotomy, and by intravenous administration of PGF2alpha or PGE2. The average infusion time was 4 hours 10 minutes, and the average total dose of PGF2alpha amounted to 2,0 mg and of PGE2 0,2 mg. Parameters of acid-base changes, carbohydrate and energic state changes, gas metabolism, and changes in coagulation and fibrinolysis in mother and in fetus were analyzed during labor and after birth. Labor activity and fetal cardiac action were monitored cardiotocographically. Checked against 50, and for the coagulation 12 uncomplicated spontaneous deliveries, we have found no disadvantageous changes in the parameters investigated.


Subject(s)
Blood Coagulation/drug effects , Energy Metabolism/drug effects , Labor, Obstetric/drug effects , Prostaglandins/pharmacology , Acid-Base Equilibrium/drug effects , Female , Fetus/drug effects , Fibrinolysis/drug effects , Humans , Infant, Newborn , Labor, Induced , Maternal-Fetal Exchange/drug effects , Pregnancy
SELECTION OF CITATIONS
SEARCH DETAIL
...